Insider · CIK 0001856296
Rakhi Kumar
Files at NPCE (NeuroPace Inc), ROIV (Roivant Sciences Ltd.). First filing Feb 18, 2025, latest Feb 18, 2025.
Rakhi Kumar files SEC Form 4 as officer and director at ROIV (Roivant Sciences Ltd.), and also at NPCE (NeuroPace Inc). Since Feb 18, 2025, Rakhi Kumar has reported 0 open-market buys worth $0 and 1 open-market sell worth $2.4M, the latest filed on Feb 18, 2025.
A track record needs three past buys with six months of prices behind them; Rakhi Kumar has 0, so none is measured yet.
The newest scored trade: sold $2.4M of ROIV on Feb 13, 2025, filed Feb 18, 2025, scored 45 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ROIV: Roivant Sciences Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | ROIVsell Roivant Sciences Ltd. | $2.4M 227,500 shares | -58% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 13, 2025 | ROIV Roivant Sciences LTD. | 227,500 0.03% of outstanding | $237M | Feb 13, 2025 | $59k |
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,153 | $13.00 | $15k | 19,160 | Mar 23, 2026 |
| Dec 19, 2025 | NPCE NeuroPace Inc | AGrant or award Common Stock | +904 | $16.59 | $15k | 18,007 | Dec 23, 2025 |
| Sep 19, 2025 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,509 | $9.94 | $15k | 17,103 | Sep 22, 2025 |
| Jun 30, 2023 | NPCE NeuroPace Inc | AGrant or award Common Stock | +3,340 | $4.49 | $15k | 3,340 | Jun 24, 2025 |
| Sep 29, 2023 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,541 | $9.73 | $15k | 4,881 | Jun 24, 2025 |
| Dec 29, 2023 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,454 | $10.31 | $15k | 6,335 | Jun 24, 2025 |
| Mar 29, 2024 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,136 | $13.20 | $15k | 7,471 | Jun 24, 2025 |
| Jun 28, 2024 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,984 | $7.56 | $15k | 9,455 | Jun 24, 2025 |
| Sep 30, 2024 | NPCE NeuroPace Inc | AGrant or award Common Stock | +2,152 | $6.97 | $15k | 11,607 | Jun 24, 2025 |
| Dec 21, 2024 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,300 | $11.53 | $15k | 12,907 | Jun 24, 2025 |
| Mar 21, 2025 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,247 | $12.02 | $15k | 14,154 | Jun 24, 2025 |
| Jun 21, 2025 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,440 | $10.41 | $15k | 15,594 | Jun 24, 2025 |
| Jun 6, 2025 | NPCE NeuroPace Inc | AGrant or award Stock Option (right to buy)derivative | +8,745 | $0.00 | $0 | 8,745 | Jun 9, 2025 |
| Feb 20, 2025 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -958 | $10.72 | $10k | 162,306 | Feb 24, 2025 |
| Feb 13, 2025 | ROIV Roivant Sciences Ltd. | MOption exercise Common Shares | +187,500 | $3.85 | $722k | 390,764 | Feb 18, 2025 |
| Feb 13, 2025 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Shares | -227,500 | $10.43 | $2.4M | 163,264 | Feb 18, 2025 |
| Feb 13, 2025 | ROIV Roivant Sciences Ltd. | MOption exercise Stock Option (Right to Buy)derivative | -187,500 | $0.00 | $0 | 312,500 | Feb 18, 2025 |
| Jan 20, 2025 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -1,057 | $11.15 | $12k | 203,264 | Jan 22, 2025 |
| Dec 20, 2024 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -3,087 | $11.57 | $36k | 204,321 | Dec 26, 2024 |
| Nov 20, 2024 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -958 | $11.49 | $11k | 207,408 | Nov 22, 2024 |
| Oct 20, 2024 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -956 | $11.92 | $11k | 208,366 | Oct 22, 2024 |
Questions about Rakhi Kumar
Answered from the filings on this page, as of the latest one.
Is Rakhi Kumar buying or selling?
Not in the last 12 months. Rakhi Kumar's latest open-market trade on SEC Form 4 was sold $2.4M of ROIV on Feb 13, 2025.
How did Rakhi Kumar's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rakhi Kumar has 0.
Where does Rakhi Kumar file Form 4?
Rakhi Kumar has filed Form 4 at ROIV (Roivant Sciences Ltd.) as Chief Accounting Officer; NPCE (NeuroPace Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.